APA (7th ed.) Citation

J, Y., Y, H., J, P., Y, Z., J, Z., & L, Q. (2026). Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure. Pediatric nephrology (Berlin, Germany), 41(5), 1361. https://doi.org/10.1007/s00467-025-07069-6

Chicago Style (17th ed.) Citation

J, Yang, He Y, Pu J, Zhang Y, Zhou J, and Qiu L. "Efficacy and Safety of Scheduled Rituximab in Children with Refractory Nephrotic Syndrome After Multi-target Therapy Failure." Pediatric Nephrology (Berlin, Germany) 41, no. 5 (2026): 1361. https://doi.org/10.1007/s00467-025-07069-6.

MLA (9th ed.) Citation

J, Yang, et al. "Efficacy and Safety of Scheduled Rituximab in Children with Refractory Nephrotic Syndrome After Multi-target Therapy Failure." Pediatric Nephrology (Berlin, Germany), vol. 41, no. 5, 2026, p. 1361, https://doi.org/10.1007/s00467-025-07069-6.